These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24685380

  • 1. New approach to implantable cardioverter-defibrillators in small pediatric patients: dorsal positioning of superior vena cava shock lead in a 3-year-old.
    Pedersen SB, Smerup MH, Nielsen JC.
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):358-60. PubMed ID: 24685380
    [No Abstract] [Full Text] [Related]

  • 2. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY, Yam N, Lun KS, Chen RH, Au TW, Yung TC.
    Europace; 2018 Sep 01; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract] [Full Text] [Related]

  • 3. Transvenous ICD lead malposition in the left ventricle: long-term follow-up.
    Franck H, Wollschläger H.
    Clin Res Cardiol; 2013 Feb 01; 102(2):159-61. PubMed ID: 22868694
    [No Abstract] [Full Text] [Related]

  • 4. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock.
    Li J, Zitron E, Katus HA, Becker R.
    Circ Arrhythm Electrophysiol; 2011 Apr 01; 4(2):e4-6. PubMed ID: 21505170
    [No Abstract] [Full Text] [Related]

  • 5. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
    Payne JE, Badertscher P, Field ME, Sturdivant JL, Gold MR.
    Circ Arrhythm Electrophysiol; 2020 Sep 01; 13(9):e008631. PubMed ID: 32703008
    [No Abstract] [Full Text] [Related]

  • 6. Recent developments in the subcutaneous ICD.
    Willcox ME, Prutkin JM, Bardy GH.
    Trends Cardiovasc Med; 2016 Aug 01; 26(6):526-35. PubMed ID: 27079889
    [Abstract] [Full Text] [Related]

  • 7. [Transcripts from automated external defibrillator are important].
    Lynge TH, Risgaard B, Philbert B, Winkel BG, Tfelt-Hansen J.
    Ugeskr Laeger; 2014 Aug 01; 176(34):. PubMed ID: 25850431
    [Abstract] [Full Text] [Related]

  • 8. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM.
    J Cardiovasc Electrophysiol; 2011 Mar 01; 22(3):280-9. PubMed ID: 20958831
    [Abstract] [Full Text] [Related]

  • 9. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb 01; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 10. Beyond the implantable cardioverter-defibrillator: are we making progress?
    Weiss JN.
    Heart Rhythm; 2008 Jun 01; 5(6 Suppl):S45-7. PubMed ID: 18456201
    [Abstract] [Full Text] [Related]

  • 11. Conductor externalization of the RIATA implantable cardioverter defibrillator lead: a challenging lead extraction requiring laser-powered sheath.
    Migliore F, Bertaglia E, Bontempi L, Verlato R, Leoni L, Iliceto S, Curnis A.
    J Cardiovasc Med (Hagerstown); 2013 Oct 01; 14(10):755-6. PubMed ID: 23996009
    [Abstract] [Full Text] [Related]

  • 12. Defibrillation for Ventricular Fibrillation: A Shocking Update.
    Nichol G, Sayre MR, Guerra F, Poole J.
    J Am Coll Cardiol; 2017 Sep 19; 70(12):1496-1509. PubMed ID: 28911514
    [Abstract] [Full Text] [Related]

  • 13. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May 19; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 14. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH, Van Gelder IC.
    Europace; 2014 Jul 19; 16(7):1032. PubMed ID: 24792457
    [No Abstract] [Full Text] [Related]

  • 15. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L.
    Circulation; 2014 Jul 01; 130(1):94-125. PubMed ID: 24815500
    [No Abstract] [Full Text] [Related]

  • 16. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
    Bolzan B, Morani G, Tomei R, Tomasi L, Borio G, Ribichini FL.
    J Cardiovasc Med (Hagerstown); 2019 Oct 01; 20(10):721-724. PubMed ID: 31389822
    [No Abstract] [Full Text] [Related]

  • 17. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov 01; 25(2):1-5. PubMed ID: 21638938
    [No Abstract] [Full Text] [Related]

  • 18. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME.
    Nat Clin Pract Cardiovasc Med; 2006 Mar 01; 3(3):115. PubMed ID: 16505838
    [No Abstract] [Full Text] [Related]

  • 19. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec 01; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 20. Ventricular fibrillation storm in a child.
    Einbinder T, Lowenthal A, Fogelman R.
    Europace; 2014 Nov 01; 16(11):1654. PubMed ID: 25344961
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.